These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 28672171)

  • 21. Recombinant adeno-associated virus utilizes host cell nuclear import machinery to enter the nucleus.
    Nicolson SC; Samulski RJ
    J Virol; 2014 Apr; 88(8):4132-44. PubMed ID: 24478436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Divergent engagements between adeno-associated viruses with their cellular receptor AAVR.
    Zhang R; Xu G; Cao L; Sun Z; He Y; Cui M; Sun Y; Li S; Li H; Qin L; Hu M; Yuan Z; Rao Z; Ding W; Rao Z; Lou Z
    Nat Commun; 2019 Aug; 10(1):3760. PubMed ID: 31434885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrograde gene transfer into neural pathways mediated by adeno-associated virus (AAV)-AAV receptor interaction.
    Sano H; Kobayashi K; Yoshioka N; Takebayashi H; Nambu A
    J Neurosci Methods; 2020 Nov; 345():108887. PubMed ID: 32739417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of cellular FKBP52 protein in intracellular trafficking of recombinant adeno-associated virus 2 vectors.
    Zhao W; Zhong L; Wu J; Chen L; Qing K; Weigel-Kelley KA; Larsen SH; Shou W; Warrington KH; Srivastava A
    Virology; 2006 Sep; 353(2):283-93. PubMed ID: 16828834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integration of adeno-associated virus (AAV) and recombinant AAV vectors.
    McCarty DM; Young SM; Samulski RJ
    Annu Rev Genet; 2004; 38():819-45. PubMed ID: 15568995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basic biology of adeno-associated virus (AAV) vectors used in gene therapy.
    Balakrishnan B; Jayandharan GR
    Curr Gene Ther; 2014; 14(2):86-100. PubMed ID: 24588706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant adeno-associated virus transduction and integration.
    Schultz BR; Chamberlain JS
    Mol Ther; 2008 Jul; 16(7):1189-99. PubMed ID: 18500252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction and packaging of herpes simplex virus/adeno-associated virus (HSV/AAV) Hybrid amplicon vectors.
    Saydam O; Glauser DL; Fraefel C
    Cold Spring Harb Protoc; 2012 Mar; 2012(3):352-6. PubMed ID: 22383640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses.
    Schreiber CA; Sakuma T; Izumiya Y; Holditch SJ; Hickey RD; Bressin RK; Basu U; Koide K; Asokan A; Ikeda Y
    PLoS Pathog; 2015 Aug; 11(8):e1005082. PubMed ID: 26244496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative analysis of the packaging capacity of recombinant adeno-associated virus.
    Dong JY; Fan PD; Frizzell RA
    Hum Gene Ther; 1996 Nov; 7(17):2101-12. PubMed ID: 8934224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor Switching in Newly Evolved Adeno-associated Viruses.
    Havlik LP; Das A; Mietzsch M; Oh DK; Ark J; McKenna R; Agbandje-McKenna M; Asokan A
    J Virol; 2021 Sep; 95(19):e0058721. PubMed ID: 34232726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.
    Hirsch ML; Wolf SJ; Samulski RJ
    Methods Mol Biol; 2016; 1382():21-39. PubMed ID: 26611576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive biophysical characterization of AAV-AAVR interaction uncovers serotype- and pH-dependent interaction.
    Fu Y; Choudhary D; Liu N; Moon Y; Abdubek P; Sweezy L; Rosconi M; Palackal N; Pyles E
    J Pharm Biomed Anal; 2023 Sep; 234():115562. PubMed ID: 37441888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired nuclear transport and uncoating limit recombinant adeno-associated virus 2 vector-mediated transduction of primary murine hematopoietic cells.
    Zhong L; Li W; Yang Z; Qing K; Tan M; Hansen J; Li Y; Chen L; Chan RJ; Bischof D; Maina N; Weigel-Kelley KA; Zhao W; Larsen SH; Yoder MC; Shou W; Srivastava A
    Hum Gene Ther; 2004 Dec; 15(12):1207-18. PubMed ID: 15684697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer.
    Kwon I; Schaffer DV
    Pharm Res; 2008 Mar; 25(3):489-99. PubMed ID: 17763830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adeno-associated virus serotypes: vector toolkit for human gene therapy.
    Wu Z; Asokan A; Samulski RJ
    Mol Ther; 2006 Sep; 14(3):316-27. PubMed ID: 16824801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-complementary adeno-associated virus 2 (AAV)-T cell protein tyrosine phosphatase vectors as helper viruses to improve transduction efficiency of conventional single-stranded AAV vectors in vitro and in vivo.
    Zhong L; Chen L; Li Y; Qing K; Weigel-Kelley KA; Chan RJ; Yoder MC; Srivastava A
    Mol Ther; 2004 Nov; 10(5):950-7. PubMed ID: 15509512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
    Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
    Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient production of recombinant adeno-associated viral vector, serotype DJ/8, carrying the GFP gene.
    Hashimoto H; Mizushima T; Chijiwa T; Nakamura M; Suemizu H
    Virus Res; 2017 Jun; 238():63-68. PubMed ID: 28571759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Structure of an AAV5-AAVR Complex at 2.5 Å Resolution: Implications for Cellular Entry and Immune Neutralization of AAV Gene Therapy Vectors.
    Silveria MA; Large EE; Zane GM; White TA; Chapman MS
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33218165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.